Stocks and Investing
Stocks and Investing
Thu, November 4, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kennen MacKay Maintained (AMGN) at Hold with Decreased Target to $216 on, Nov 3rd, 2021
Kennen MacKay of RBC Capital, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $217 to $216 on, Nov 3rd, 2021.
Kennen has made no other calls on AMGN in the last 4 months.
There are 2 other peers that have a rating on AMGN. Out of the 2 peers that are also analyzing AMGN, all agree with Kennen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $235 on, Tuesday, October 12th, 2021
- Narumi Nakagiri of "Daiwa Capital" Downgraded from Buy to Hold and Held Target at $220 on, Thursday, September 23rd, 2021
Contributing Sources